<DOC>
	<DOC>NCT02026635</DOC>
	<brief_summary>A research study to determine if heart failure can be medically managed using data collected from cardiac monitoring devices</brief_summary>
	<brief_title>Cardiac Compass With Optivol速 to Negate Future Inpatient Re-admissions Through Monitoring in HF Patients (CONFIRM-HF)</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>At least 18 years of age Admission for worsening of HF Discharged to home Have appropriate cardiac device with OptiVol速 implanted for at least 34 days prior to enrollment Enrolled in Carelink速 system and able to transmit data Able to participate for at least 3 months Post heart transplant or actively listed Endstage (Stage D) HF, including treatment with chronic ionotropic drugs or left ventricular assist device support Stage IV or V chronic renal dysfunction (GFR &lt;25 mol/min per 1.73 M2) Severe Chronic Obstructive Pulmonary Disease (COPD) requiring home oxygen Severe pulmonary hypertension not due to leftsided HF</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>heart failure</keyword>
	<keyword>Optivol速 cardiac device</keyword>
	<keyword>Medtronic CareLink</keyword>
</DOC>